KMU VC participates in WHO meeting on cardiovascular disease in Geneva

Peshawar - Professor Dr Abdul Jalil Khan, Vice-Chancellor of Khyber Medical University (KMU), Peshawar, participated in a five-day, in-person meeting of the World Health Organization's (WHO) Guideline Development Group (GDG) in Geneva, Switzerland, to contribute to the development of international guidelines on the management of dyslipidaemia for the primary and secondary prevention of cardiovascular diseases. Prof Jalil Khan, who was previously selected as an expert member of this prestigious WHO committee through an international selection process, is the only expert from Pakistan appointed to the Guideline Development Group. His selection reflects international recognition of his expertise in family medicine, primary healthcare, public health and health systems strengthening. The WHO Guideline Development Group brings together distinguished international experts from leading academic, clinical and research institutions worldwide. Its members represent a wide range of specialisations, including cardiology, internal medicine, endocrinology, epidemiology, public health and evidence-based guideline development. The Geneva meeting provided an important opportunity for experts to collectively review scientific evidence and contribute to the development of evidence-based recommendations for the prevention and management of cardiovascular diseases. Particular emphasis was placed on improving the identification and management of dyslipidaemia, a major risk factor for heart attacks and strokes. Prof Jalil Khan's participation brought valuable perspectives from primary healthcare systems and low- and middle-income countries, particularly highlighting the importance of developing practical, equitable and evidence-based recommendations that can be implemented across diverse healthcare settings. With extensive clinical and academic experience in the United Kingdom's National Health Service (NHS), along with his leadership in family medicine, primary healthcare development and health systems strengthening in Pakistan, Prof Jalil Khan brings a unique combination of international clinical expertise and practical health systems experience to this global initiative. The development of these WHO guidelines is expected to help countries strengthen cardiovascular disease prevention, improve clinical decision-making and integrate effective non-communicable disease management into primary healthcare services. Prof Jalil Khan's participation in this important international initiative highlights the growing contribution of Pakistani healthcare professionals to global health policy and evidence-based guideline development. It also further strengthens Khyber Medical University's international academic standing and its role in global health initiatives.